RicardoDanielParrondoMD

PubMed

• A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia.
  Parrondo, R., Dutta, N., LaPlant, B., Elliott, J., Fernandez, A., Zimmerman, A., Cicco, G., Han, B., Heslop, K., Chapin, D., Sher, T., Roy, V., Rasheed, A., Das, S., C...> ;British Journal of Haematology. 2024 Jan 29
• Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives.
  Claudio Cerchione, Ricardo D Parrondo, Sikander Ailawadhi> ;Frontiers in Oncology. 2024 Jan 1
• Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Prelim...
  Saurav Das, Sikander Ailawadhi, Taimur Sher, Vivek Roy, Andre Fernandez, Ricardo D Parrondo> ;Current Oncology. 2023 Oct 31
• The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers.
  Sikander Ailawadhi, Meghna Ailawadhi, Navnita Dutta, Ricardo D Parrondo, Vivek Roy, Taimur Sher, Mizba Baksh, Ahsan Rasheed, Saurav Das, Andre J Fernandez, Aneel Paulu...> ;Cancer Medicine. 2023 Sep 1
• 2 citations
  Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
  Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafa...> ;Blood. 2023 Nov 30
• Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation...
  Farah Yassine, Mohamed A Kharfan-Dabaja, Athanasios Tsalantsanis, Vivek Roy, Abba C Zubair, Hemant S Murthy, Ernesto Ayala, Madiha Iqbal, Taimur Sher, Sikander Ailawad...> ;Bone Marrow Transplantation. 2023 Oct 1
• 3 citations
  Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial.
  Sikander Ailawadhi, Zi Chen, Bo Huang, Aneel Paulus, Mary C Collins, Lei Tommy Fu, Mingyu Li, Mohammad Ahmad, Lichuang Men, Hengbang Wang, Matthew S Davids, Eric Liang...> ;Clinical Cancer Research. 2023 Jul 5
• Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
  Muhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, Vivek Roy, Taimur Sher, Victoria R Alegria, Rahma M Warsame, Rafael Fonseca, Ahsan Rasheed, Wilson I Gonsa...> ;Anti-Cancer Drugs. 2024 Jan 1
• 2 citations
  Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
  Naresh Bumma, Binod Dhakal, Raphael Fraser, Noel Estrada-Merly, Kenneth Anderson, César O Freytes, Gerhard C Hildebrandt, Leona Holmberg, Maxwell M Krem, Cindy Lee, La...> ;Cancer. 2023 Jul 15
• 2 citations
  AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.
  Sikander Ailawadhi, Ricardo D Parrondo, Navnita Dutta, Bing Han, Gina Ciccio, Yesesri Cherukuri, Victoria R Alegria, Betsy R LaPlant, Vivek Roy, Taimur Sher, Brett Edw...> ;Cancers. 2023 Jan 12
• 2 citations
  IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies.
  Ricardo D Parrondo, Madiha Iqbal, Reinhard Von Roemeling, Christina Von Roemeling, Han W Tun> ;Frontiers in Immunology. 2023 Jan 1
• 6 citations
  Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Saad S Kenderian, Eli Muchtar, Yucai Wang, Amber B Koehler, Ricardo Parrondo, Susan M Schwager, Min ...> ;British Journal of Haematology. 2022 Oct 1
• 4 citations
  Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.
  Sikander Ailawadhi, Ricardo D Parrondo, Muhamad Alhaj Moustafa, Betsy R LaPlant, Victoria Alegria, Dustin Chapin, Vivek Roy, Taimur Sher, Aneel Paulus, Asher A Chanan-...> ;Hematological Oncology. 2022 Oct 1
• 4 citations
  Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Asher A Chanan-Khan, Saad S Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B Koehler,...> ;Blood Cancer Journal. 2022 Sep 1
• 4 citations
  Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma.
  Ricardo D Parrondo, Aneel Paulus, Sikander Ailawadhi> ;Cancers. 2022 Jul 8
• 5 citations
  Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
  Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B Alkhateeb, Mark R Litzow, Patricia Greipp, Taimur Sher, Leif Bergsa...> ;Blood Cancer Journal. 2022 Jun 1
• 8 citations
  Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis.
  Ricardo D Parrondo, Keren Sam, Ahsan Rasheed, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikander Ailawadhi> ;Blood Cancer Journal. 2022 Apr 19
• Myelomatous ascites and pleural effusion in relapsed multiple myeloma.
  Mizba Baksh, Ke Li, Liuyan Jiang, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikander Ailawadhi, Ricardo D Parrondo, Muhamad Alhaj Moustafa> ;Clinical Case Reports. 2022 Feb 1
• 1 citations
  Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation.
  Adam M Kase, Catherine Bullock, Ricardo Parrondo, Muhamad Alhaj Moustafa, Madiha Iqbal, K David Li, Ephraim E Parent, Han Tun> ;Blood and Lymphatic Cancer. 2022 Jan 1
• 1 citations
  Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature.
  Mizba Baksh, Liuyan Jiang, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikander Ailawadhi, Ricardo D Parrondo, Bhatia, U.> ;Clinical Case Reports. 2021 Dec 1
• 10 citations
  Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
  Thejus T. Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, Kianna Nguyen, Meghna Ailawadhi, Ayesha Samreen, Ricardo D. Parrondo, Taimur Sher, Vivek Roy, Rami Manochakian,...> ;Cancers. 2021 Nov 18
• Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia
  Ricardo D. Parrondo, Aneel Paulus, Victoria R. Alegria, David Liebowitz, Chelsea M. Johnson, Raphael Clynes, Vivek Roy, David M. Menke, Liuyan Jiang, Asher Chanan-Khan...> ;Leukemia & Lymphoma. 2021 Nov 16
• 10 citations
  Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell...
  Surbhi Sidana, Shaji Kumar, Raphael Fraser, Noel Estrada-Merly, Sergio Giralt, Vaibhav Agrawal, Larry D. Anderson, Mahmoud Aljurf, Rahul Banerjee, Asad Bashey, Minoo B...> ;Transplantation and Cellular Therapy. 2021 Nov 12
• 7 citations
  Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia.
  Zaid Abdel Rahman, Ricardo D. Parrondo, Michael G. Heckman, Mikolaj Wieczorek, Kevin C. Miller, Hassan B. Alkhateeb, Lisa Z. Sproat, Hemant S. Murthy, William J. Hogan...> ;British Journal of Haematology. 2021 Oct 25
• 2 citations
  Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
  Oren Pasvolsky, Moshe Yeshurun, Raphael Fraser, Noel Estrada-Merly, Uri Rozovski, Liat Shargian-Alon, Amer Assal, Rahul Banerjee, Naresh Bumma, Robert Peter Gale, Patr...> ;Bone Marrow Transplantation. 2021 Oct 4
• Join now to see all